For example, in early stages of the serrated pathway, mutation of BRAF elevates the expression of tumor suppressor genes p16 and insulin-like growth factor-binding protein 7 (IGFBP7) holding the microvesicular hyperplastic polyp (MVHP) to a small and nonprogressive lesion [96]. Here, IGFBP7 is linked to hyperplastic polyp.